Innate Immune Receptor NLRX1: Potential Modulator of Glioblastoma PathophysiologyDurgesh Meena, Sushmita Jha, Divya Shivakumar et al.|bioRxiv (Cold Spring Harbor Laboratory)|2024Cited by 4
Innate Immune Receptor NLRX1: Potential Modulator of Glioblastoma PathophysiologyDurgesh Meena, Sushmita Jha, Sushmita Rajkhowa et al.|Journal of Cellular Physiology|2026Cited by 2
NLRP12-mediated Glioblastoma-Astrocyte Cross-talk Promotes Tumor GrowthSushmita Rajkhowa, Sushmita Jha, Durgesh Meena et al.|bioRxiv (Cold Spring Harbor Laboratory)|2025Cited by 1
Cover Image, Volume 241, Number 5, May 2026Durgesh Meena, Sushmita Jha, Divya Shivakumar et al.|Journal of Cellular Physiology|2026Cited by 0
Innate immune cross-talk of glioblastoma pathophysiology: Understanding NLRP3 and NLRP12.Sushmita Rajkhowa, Sushmita Jha, Durgesh Meena et al.|Journal of Clinical Oncology|2026Cited by 0